Patents Assigned to DiamiR, LLC
  • Methods of using miRNAs from bodily fluids for detection and differentiation of neurodegenerative diseases
    Patent number: 11149313
    Abstract: The invention is directed to methods for diagnosis and differentiation of neurodegenerative diseases (NDs), by quantifying miRNAs in bodily fluids.
    Type: Grant
    Filed: March 21, 2017
    Date of Patent: October 19, 2021
    Assignee: DIAMIR, LLC
    Inventors: Samuil R. Umansky, Kira S. Sheinerman, Vladimir G. Tsivinsky
  • Methods of using miRNAs from bodily fluids for detection and monitoring of Parkinson's disease (PD)
    Patent number: 11098362
    Abstract: The invention is directed to methods for early diagnosis, progression and treatment monitoring of Parkinson's disease (PD) and its differentiation from other neurodegenerative diseases by quantifying brain-enriched miRNA in bodily fluids.
    Type: Grant
    Filed: November 17, 2014
    Date of Patent: August 24, 2021
    Assignee: DIAMIR, LLC
    Inventors: Samuil R. Umansky, Kira S. Sheinerman, Vladimir G. Tsivinsky
  • Methods of using miRNA from bodily fluids for diagnosis and monitoring of neurodevelopmental disorders
    Patent number: 10975436
    Abstract: The invention provides methods for diagnosis and monitoring of Rett syndrome and other neurodevelopmental disorders by quantitative analysis of miRNAs in bodily fluids.
    Type: Grant
    Filed: July 5, 2018
    Date of Patent: April 13, 2021
    Assignee: DIAMIR, LLC
    Inventors: Samuil R. Umansky, Kira S. Sheinerman, Vladimir G. Tsivinsky
  • miRNA-based methods for detecting and monitoring aging
    Patent number: 10781487
    Abstract: The present invention is directed to methods for detection, treatment monitoring, and slowing of aging by quantifying miRNAs in bodily fluids.
    Type: Grant
    Filed: July 24, 2018
    Date of Patent: September 22, 2020
    Assignee: DIAMIR, LLC
    Inventors: Kira S. Sheinerman, Vladimir G. Tsivinsky, Samuil R. Umansky
  • miRNA-based universal screening test (UST)
    Patent number: 10472681
    Abstract: Described are methods for early noninvasive or minimally invasive detection of pathological changes in organ systems/organs/tissues/cells by quantifying organ system-/organ-/tissue-/cells type-enriched miRNA in bodily fluids.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: November 12, 2019
    Assignee: DIAMIR, LLC
    Inventors: Samuil R. Umansky, Kira S. Sheinerman, Vladimir Tsivinsky
  • Methods of using miRNA from bodily fluids for early detection and monitoring of mild cognitive impairment (MCI) and Alzheimer's disease (AD)
    Patent number: 10246747
    Abstract: Described are methods for early diagnosis and progression monitoring of Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) by quantifying neurite and/or synapse miRNAs in bodily fluids.
    Type: Grant
    Filed: December 23, 2016
    Date of Patent: April 2, 2019
    Assignee: DiamiR, LLC
    Inventors: Samuil R. Umansky, Kira S. Sheinerman, Vladimir Tsivinsky
  • METHODS OF USING MIRNAS FROM BODILY FLUIDS FOR DETECTION AND DIFFERENTIATION OF NEURODEGENERATIVE DISEASES
    Publication number: 20190093167
    Abstract: The invention is directed to methods for diagnosis and differentiation of neurodegenerative diseases (NDs), by quantifying miRNAs in bodily fluids.
    Type: Application
    Filed: March 21, 2017
    Publication date: March 28, 2019
    Applicant: DIAMIR, LLC
    Inventors: Samuil R. UMANSKY, Kira S. SHEINERMAN, Vladimir G. TSIVINSKY
  • miRNA-BASED METHODS FOR DETECTING AND MONITORING AGING
    Publication number: 20190024169
    Abstract: The present invention is directed to methods for detection, treatment monitoring, and slowing of aging by quantifying miRNAs in bodily fluids.
    Type: Application
    Filed: July 24, 2018
    Publication date: January 24, 2019
    Applicant: DiamiR, LLC
    Inventors: Kira S. Sheinerman, Vladimir G. Tsivinsky, Samuil R. Umansky
  • METHODS OF USING miRNA FROM BODILY FLUIDS FOR DIAGNOSIS AND MONITORING OF NEURODEVELOPMENTAL DISORDERS
    Publication number: 20180312925
    Abstract: The invention provides methods for diagnosis and monitoring of Rett syndrome and other neurodevelopmental disorders by quantitative analysis of miRNAs in bodily fluids.
    Type: Application
    Filed: July 5, 2018
    Publication date: November 1, 2018
    Applicant: DiamiR, LLC
    Inventors: Samuil R. Umansky, Kira S. Sheinerman, Vladimir G. Tsivinsky
  • miRNA-BASED UNIVERSAL SCREENING TEST (UST)
    Publication number: 20170362656
    Abstract: Described are methods for early noninvasive or minimally invasive detection of pathological changes in organ systems/organs/tissues/cells by quantifying organ system-/organ-/tissue-/cells type-enriched miRNA in bodily fluids.
    Type: Application
    Filed: May 26, 2017
    Publication date: December 21, 2017
    Applicant: DIAMIR, LLC
    Inventors: Samuil R. Umansky, Kira S. Sheinerman, Vladimir Tsivinsky
  • miRNA-based universal screening test (UST)
    Patent number: 9803242
    Abstract: Described are methods for early noninvasive or minimally invasive detection of pathological changes in organ systems/organs/tissues/cells by quantifying organ system-/organ-/tissue-/cells type-enriched miRNA in bodily fluids.
    Type: Grant
    Filed: April 18, 2012
    Date of Patent: October 31, 2017
    Assignee: DiamiR, LLC
    Inventors: Samuil R. Umansky, Kira S. Sheinerman, Vladimir Tsivinsky
  • METHODS OF USING miRNA FROM BODILY FLUIDS FOR EARLY DETECTION AND MONITORING OF MILD COGNITIVE IMPAIRMENT (MCI) AND ALZHEIMER'S DISEASE (AD)
    Publication number: 20170107575
    Abstract: Described are methods for early diagnosis and progression monitoring of Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) by quantifying neurite and/or synapse miRNAs in bodily fluids.
    Type: Application
    Filed: December 23, 2016
    Publication date: April 20, 2017
    Applicant: DiamiR, LLC
    Inventors: Samuil R. Umansky, Kira S. Sheinerman, Vladimir Tsivinsky
  • Methods of using miRNA from bodily fluids for early detection and monitoring of mild cognitive impairment (MCI) and alzheimer's disease (AD)
    Patent number: 9556487
    Abstract: Described are methods for early diagnosis and progression monitoring of Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) by quantifying neurite and/or synapse miRNAs in bodily fluids.
    Type: Grant
    Filed: April 18, 2012
    Date of Patent: January 31, 2017
    Assignee: DIAMIR, LLC
    Inventors: Samuil R. Umansky, Kira S. Sheinerman, Vladimir Tsivinsky
  • METHODS OF USING MIRNAS FROM BODILY FLUIDS FOR DETECTION AND MONITORING OF PARKINSON'S DISEASE (PD)
    Publication number: 20160273043
    Abstract: The invention is directed to methods for early diagnosis, progression and treatment monitoring of Parkinson's disease (PD) and its differentiation from other neurodegenerative diseases by quantifying brain-enriched miRNA in bodily fluids.
    Type: Application
    Filed: November 17, 2014
    Publication date: September 22, 2016
    Applicant: DIAMIR, LLC
    Inventors: Samuil R. UMANKSY, Kira S. Sheinerman, Vladimir G. Tsivinsky
  • METHODS OF USING SMALL RNA FROM BODILY FLUIDS FOR DIAGNOSIS AND MONITORING OF NEURODEGENERATIVE DISEASES
    Publication number: 20140357507
    Abstract: Described are methods for detection of neuronal pathologies using quantitative analysis in bodily fluids of synapse and/or neurite small RNAs and application of these methods to early diagnosis and monitoring of neurodegenerative diseases and other neurological disorders.
    Type: Application
    Filed: January 2, 2014
    Publication date: December 4, 2014
    Applicant: DIAMIR, LLC
    Inventors: Samuil R. UMANSKY, Kira S. SHEINERMAN
  • miRNA-BASED UNIVERSAL SCREENING TEST (UST)
    Publication number: 20140256562
    Abstract: Described are methods for early noninvasive or minimally invasive detection of pathological changes in organ systems/organs/tissues/cells by quantifying organ system-/organ-/tissue-/cells type-enriched miRNA in bodily fluids.
    Type: Application
    Filed: April 18, 2012
    Publication date: September 11, 2014
    Applicant: DiamiR, LLC
    Inventors: Samuil R. Umansky, Kira S. Sheinerman, Vladimir Tsivinsky
  • METHODS OF USING miRNA FROM BODILY FLUIDS FOR EARLY DETECTION AND MONITORING OF MILD COGNITIVE IMPAIRMENT (MCI) AND ALZHEIMER'S DISEASE (AD)
    Publication number: 20140120545
    Abstract: Described are methods for early diagnosis and progression monitoring of Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) by quantifying neurite and/or synapse miRNAs in bodily fluids.
    Type: Application
    Filed: April 18, 2012
    Publication date: May 1, 2014
    Applicant: DIAMIR, LLC
    Inventors: Samuil R. Umansky, Kira S. Sheinerman, Vladimir Tsivinsky
  • Methods of using small RNA from bodily fluids for diagnosis and monitoring of neurodegenerative diseases
    Patent number: 8648017
    Abstract: Described are methods for detection of neuronal pathologies using quantitative analysis in bodily fluids of synapse and/or neurite small RNAs and application of these methods to early diagnosis and monitoring of neurodegenerative diseases and other neurological disorders.
    Type: Grant
    Filed: November 4, 2010
    Date of Patent: February 11, 2014
    Assignee: DiamiR, LLC
    Inventors: Samuil R. Umansky, Kira S. Sheinerman
  • METHODS OF USING SMALL RNA FROM BODILY FLUIDS FOR DIAGNOSIS AND MONITORING OF NEURODEGENERATIVE DISEASES
    Publication number: 20120252693
    Abstract: Described are methods for detection of neuronal pathologies using quantitative analysis in bodily fluids of synapse and/or neurite small RNAs and application of these methods to early diagnosis and monitoring of neurodegenerative diseases and other neurological disorders.
    Type: Application
    Filed: November 4, 2010
    Publication date: October 4, 2012
    Applicant: DiamiR, LLC
    Inventors: Samuil R. Umansky, Kira S. Sheinerman